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Abstract 34 
Reasons for performing the study:  As growth hormone (GH) increases lean body mass, it 35 
could be a therapy for obese horses. However, GH use induces hyperinsulinaemia in some 36 
species, so further investigation is warranted. 37 
Objectives: To investigate the effects of feeding, exercise and GH therapy on basal insulin 38 
concentrations in healthy horses. 39 
Methods: Blood samples were obtained every 30 min from 12 geldings over 24 h, to establish 40 
basal serum insulin concentrations, before undergoing a 3 wk exercise program. Horses were 41 
allocated into two groups and exercised for another 4 wks. Group A received daily i.m 42 
injections of recombinant equine GH (eGH); 5 mg/day for 5 days, then 12.5 mg/d for 16 days. 43 
Blood samples were taken daily before feeding. Results were obtained from the data for basal 44 
insulin concentrations over 24 h and by comparing insulin versus time area under curve of 45 
Groups A and B using a t-test.  46 
Results: Horses demonstrated insulin peaks within 2 h of feeding: 577 ± 108.3 pmol/l at 0930 47 
h and 342.4 ± 75.7 pmol/l at 1730 h, despite receiving the same meal. The nadir was evident 48 
between midnight and 0730 h. Exercise had no effect on basal insulin concentrations prior to 49 
eGH administrations. The eGH injections increased serum insulin concentrations (P = 0.01) 50 
within Group A, from 44.4 ± 15.3 pmol/l to 320.9 ± 238.2 pmol/l by Day 12. Exogenous GH 51 
caused variable hyperinsulinaemia, which was alleviated once eGH administration ceased.  52 
Conclusions: single serum samples taken prior to the morning meal provide basal insulin 53 
concentrations. Exercise did not change basal insulin concentrations. However, eGH 54 
injections increased basal insulin concentrations in horses which were not ameliorated by 55 
exercise.  56 
Potential relevance: As exercise training did not reduce the hyperinsulinaemia caused by 57 
eGH administration, this therapy is not recommended to address obesity in insulin-resistant 58 
equids. 59 
 60 
 61 
 62 
 63 
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Introduction 64 
Insulin is a major regulatory hormone in glucose and fat metabolism, and is the only hormone 65 
to directly lower blood glucose [1]. Serum insulin concentrations are affected by feeding, and 66 
possibly by diurnal variations in cortisol [2], although the few previous studies have presented 67 
conflicting results, likely influenced by small sample size and varying feeding regimes (fasting 68 
versus fed states) [3,4]. 69 
 70 
Insulin, along with obesity [5], has long been implicated in the pathophysiology of laminitis, 71 
with some laminitic ponies being more insulin resistant than non-laminitic ponies [6,7]. Also 72 
prolonged hyperinsulinaemia causes laminitis in ponies and horses with no previous history of 73 
laminitis or insulin resistance [8,9,10].   74 
 75 
Obesity, insulin resistance and laminitis may arise from a combination of poor management 76 
practices in genetically susceptible individuals [2]. The accumulation of excessive body fat in 77 
these individuals leads directly to an insulin refractory state, limiting the uptake and utilisation 78 
of glucose by other tissues such as skeletal muscle. Meanwhile, insulin stimulates glucose 79 
metabolism in adipose tissue leading to lipogenesis [1]. Thus, an abundance of insulin in the 80 
already obese horse supports fat deposition, undermining any attempt at weight loss.  81 
 82 
Growth hormone (GH) is a repartitioning agent which stimulates protein deposition in muscle, 83 
while having a catabolic effect in adipose tissue by antagonising the lipogenic action of insulin 84 
[11] and promoting the lipolytic effect of catecholamines. These repartitioning effects have 85 
been reported in many species including cattle, sheep, pigs [12] and horses [13].  86 
 87 
A study of obese men given GH therapy showed that total body fat decreased with a 88 
corresponding improvement in insulin sensitivity [14]. Therefore, treating obese horses with 89 
GH, along with a calorie-controlled diet, may lead to an increase in lean body mass, thus 90 
enhancing insulin sensitivity and decreasing the risk of laminitis. This may be an option in 91 
those horses whose ability to exercise is compromised, or for an individual in which diet and 92 
exercise have been unsuccessful in reducing obesity.   93 
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 94 
Further, GH stimulates the production of insulin-like growth factor-1 (IGF-1) [15] which mimics 95 
the effect of insulin by stimulating glucose uptake by the cells. This should, in theory, reduce 96 
insulin secretion. In practice, however, GH therapy has been shown to induce insulin 97 
resistance in some species after prolonged use [16, 17]. The increased insulin concentrations 98 
are likely due to a decrease in insulin action post receptor rather than a concomitant increase 99 
in blood glucose [16]. It is also known that GH stimulates β-cell proliferation, insulin gene 100 
expression, insulin synthesis and secretion [18]. Thus, while GH may have potential to aid in 101 
adipose loss in obese horses, it is important to ascertain the risk of inducing insulin 102 
resistance, exacerbating hyperinsulinaemia and thus increasing the possibility of laminitis. 103 
Further, daily exercise has been shown to improve insulin sensitivity in horses [19, 20], but it 104 
remains to be seen if exercise sufficiently counteracts insulin resistance induced by 105 
exogenous GH. 106 
 107 
The aims of this study were to determine the effects on basal insulin concentration of: diurnal 108 
rhythm and feeding and 7 weeks of exercise which included a 3-week course of GH 109 
administration under the same feeding and exercise conditions. The first hypothesis was that 110 
diurnal rhythm, time of feeding and exercise training would result in variations in baseline 111 
insulin concentrations. A second hypothesis was that prolonged GH administration would 112 
affect baseline insulin concentrations independently of these effects. 113 
 114 
Materials and Methods 115 
Study 1. Insulin secretion over a 24-hour period 116 
Twelve light horse geldings in moderate body condition, aged 2 to 13 yr (6.3 ± 3.4 yr, BW 460 117 
± 15.8 kg, BCS 2.5 on a scale of 5 [21]) were used to determine the 24-h secretory pattern of 118 
insulin. From this, it could then be established the time(s) of day when insulin concentrations 119 
were most stable and at basal levels. As interruptions to the daily routines can alter hormone 120 
secretion patterns [22], all horses were allowed 5 days to acclimatize before the study and to 121 
become accustomed to a 12-h dark-light cycle. All horses were fed a daily ration of 3 kg oats, 122 
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2kg wheaten chaff, 3 kg lucerne chaff, 3 kg oaten hay, 60 g salt and 60 g calcium carbonate, 123 
divided into two meals given at 0730 h and 1600 h. 124 
 125 
On the sampling day, each horse was fitted with a 14-gauge jugular cannula (Angiocath)a 126 
attached to a 150-cm length of extension tubing (Tuta)b, and 3-way stopcock (BD)c. Blood 127 
samples (10 ml) were taken from all horses every 30 min for a 26-h period, commencing at 128 
1000 h. The first three samples were discarded to eliminate the stress response to 129 
cannulation, and to allow the horses to become accustomed to the sampling procedure. Blood 130 
samples were collected into plain glass tubes (Vacutainer)d, allowed to clot for 2 h at room 131 
temperature, then centrifuged at 4°C and 3,500 x g for 30 min. Serum was collected and 132 
stored at -20°C until assayed. These samples were assayed in duplicate for insulin 133 
concentration using a commercial diagnostic kit (Count-a-Coat Insulin RIA)e validated for 134 
horses [23].  135 
 136 
Study 2. Effect of exercise and eGH administration on serum insulin concentrations 137 
Having established when basal insulin concentrations occurred in Study 1, the same group of 138 
horses then underwent an exercise regimen to determine what effects exercise training may 139 
have on basal insulin concentrations.  The horses were in paddock condition and introduced 140 
to an incremental exercise regimen using a high-speed treadmill. They were worked 6 days a 141 
week for 7 weeks at speeds to maintain a heart rate of 150 to 160 bpm, with increasing 142 
duration, shown in Table 1. This was in addition to a 4-min warm up and a 2-min cool-down at 143 
the walk. Blood samples were taken daily at 0700 h before feeding or exercise for the 144 
duration of the study and processed as described above.    145 
 146 
At the start of Week 4, the 12 horses were divided at random into two groups. Six horses in 147 
Group A commenced treatment with daily i.m. injections of recombinant equine growth 148 
hormone (eGH) (Bresagen)f. A dose of 5 mg/horse was given for the first 5 days, followed by 149 
12.5 mg/horse for a further 16 days as advised by the manufacturer. All injections were given 150 
at 1700 h. The horses in Group B (control group) received daily i.m. injections of sterile water 151 
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(2 to 5 ml). Daily blood samples continued to be collected at 0700 h, before any feed was 152 
given, before exercise and 10 h before the daily GH injection. 153 
 154 
The following samples from each horse were assayed for insulin concentration: five baseline 155 
samples (last four days prior to and morning of GH administration), 21 samples taken during 156 
the GH administration period and seven samples taken for the first seven days after GH 157 
administration ceased. 158 
 159 
All procedures were approved by the Animal Care and Ethics Committee at Charles Sturt 160 
University, Wagga Wagga, Australia and were in accordance with the Australian Code of 161 
Practice for the Care and use of Experimental Animals for Scientific Purposes.  162 
 163 
Data analysis 164 
Insulin concentrations were calculated from a standard curve using Graphpad Prism 5 165 
softwareg. The mean 24-hour secretion pattern for serum insulin concentrations was 166 
compared visually with secretion pattern obtained from the same serum samples for cortisol. 167 
A diurnal rhythm should clearly demonstrate both a nadir and a zenith. 168 
 169 
The GH administration trial results were analysed using SigmaPlot 8.0 softwareh and 170 
Microsoft Excel 2007i. Baseline insulin concentrations were plotted against time for each 171 
horse to confirm that there was no difference between mean insulin concentrations between 172 
the two groups. A linear regression was performed on insulin concentrations versus time to 173 
confirm that hormone concentrations did not alter significantly over time in control horses (i.e. 174 
no exercise effect). The linear regression analysis was used to account for the variation in 175 
insulin concentration evident from day to day. 176 
 177 
The data for horses in Group A were analysed by comparing pre-treatment, treatment and 178 
post-treatment segments, using area under the concentration-time curve over all time (AUC). 179 
Calculation of AUC provides an indication of the total exposure to a hormone over time. It also 180 
allows for the apparent erratic behaviour of a hormone, where the peaks and troughs do not 181 
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fit a pattern of regular frequency. Area under the curve for each segment was calculated for 182 
each horse using Simpson’s Rule, then adjusted for time by dividing by the number of days in 183 
that segment. The adjusted AUC values were subjected to an F-test which revealed unequal 184 
variances. Accordingly, the data were subjected to a log-transformation before undergoing 185 
unpaired t-tests between the treatment and control groups during the eGH administration 186 
period and paired t-tests for Group A to compare treatment period means and pre- and post-187 
treatment values, respectively. A P-value of < 0.05 was considered significant. All results are 188 
presented ± SEM. 189 
 190 
Results 191 
 Study 1. Insulin secretion over a 24-hour period 192 
A diurnal rhythm of serum cortisol from these horses has been reported elsewhere [24] with a 193 
nadir of 49.2 ± 13.6 nmol/l at midnight and a zenith of 144.2 ± 27.2 nmol/l at 0730 h, as 194 
shown in Figure 1A. Insulin secretion showed no such pattern with two peaks occurring during 195 
daylight hours (Figure 1B). The larger sustained peak occurred after the morning meal at 196 
0930 h, reaching a concentration Cmax of 577.1 ± 108.3 pmol/l. The second peak occurred at 197 
1730 h reaching 342.4 ± 75.7 pmol/l, despite the same meal being fed. Both post-prandial 198 
peak insulin concentrations were reached within two hours. Insulin concentrations were 199 
relatively stable and at their lowest between midnight and 0730 h, just prior to the morning 200 
meal being fed. 201 
 202 
Study 2. Effect of exercise and eGH administration on serum insulin concentrations 203 
Although insulin concentrations fluctuated from day to day during the conditioning program, 204 
there was no effect of exercise on daily basal insulin concentrations in samples taken from 205 
the control horses during the entire exercise program, as shown in Figure 2. The equation of 206 
the regression line is y0 = 10.2 + 0.07x, with the slope not significantly different from zero (P = 207 
0.4, r2 = 0.01). Many samples collected returned insulin concentrations below that of the 208 
lowest standard, so were not included in the analysis.  209 
 210 
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Initially there was no difference in plasma insulin concentrations between the two groups, as 211 
shown in Figure 3, prior to the horses being administered eGH (Days -4 to 0).  During the first 212 
3 days of eGH treatment there was an apparent increase in serum insulin concentrations, 213 
after which concentrations approached those of the control group during Days 4 and 5.   214 
Following this, insulin concentrations rose again, coinciding with the increased dose of eGH. 215 
Maximum basal insulin concentration was reached on Day 12 of eGH administration at 320.9 216 
± 238.2 pmol/l, compared with 51.6 ± 17.7 pmol/l for the control group. Insulin concentrations 217 
remained elevated for the rest of the administration period, although the concentrations were 218 
erratic and highly variable between horses. On the final day of eGH therapy, basal insulin 219 
concentration in the control horses was 64.1 ± 29.8 pmol/l compared with the eGH-treated 220 
horses at 162.0 ± 32.0 pmol/l. Once eGH administration had ceased, the mean serum insulin 221 
concentration of Group A fell rapidly to within the control range by the following day.   222 
 223 
The variation in insulin concentrations between times and animals was considerable (range < 224 
39.6 to 1500.1 pmol/l). For statistical purposes, analyses were performed after a log 225 
transformation of the data (Figure 3A). This demonstrated a significant effect of eGH 226 
administration both between Group A and B (P = 0.02) for the eGH administration period and 227 
within Group A when pre-treatment AUC and treatment AUC were compared (P = 0.01).  228 
 229 
Discussion 230 
Several hormones follow a circadian rhythm and the present study was designed, in part, to 231 
determine how insulin concentrations might vary over the course of 24 hours, in order to 232 
establish when insulin concentrations are at their lowest. A distinct diurnal pattern for cortisol 233 
secretion in both sedentary, unperturbed horses at pasture, and stabled horses undergoing 234 
exercise has been demonstrated [22]. However, it was found that the circadian rhythm could 235 
be obliterated by minor disruptions such as moving a horse to a new environment [22]. The 236 
horses in the present study were housed in their stables for five days before the study and the 237 
presence of a circadian rhythm for cortisol in all 12 geldings with a nadir in the late evening 238 
and a zenith early in the morning showed they had become acclimatised to their new 239 
environment [24]. 240 
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 241 
Having established that the horses exhibited a circadian rhythm for cortisol, it can be seen in 242 
comparison, that insulin secretion did not show a diurnal rhythm. Instead, two peaks can be 243 
clearly seen, with a sustained peak at 0930 h and another at 1730 h. Both peaks occurred 244 
between one and a half to two hours post-feeding. This is in contrast to a report by Evans et 245 
al [3] which documented peak insulin concentrations 4 hours after feeding. This may be due 246 
to differences in the ration eaten by the horses in this study. Although cortisol secretion may 247 
influence insulin concentrations by mobilising glucose stores [1], it is more likely that insulin 248 
concentrations here were driven by the consumption of a meal.   249 
 250 
The insulin secretion pattern in these fed horses was quite different from that exhibited by 251 
fasted horses. While no circadian rhythm was seen in the fasted horses [4], these horses 252 
demonstrated approximately six insulin concentration peaks and in contrast to the present 253 
study, several of these were seen during the hours of darkness. In the fed horses, insulin 254 
concentrations gradually decreased from a peak following the afternoon meal to their lowest 255 
levels around midnight (Figure 1A) and varied little until the horses were fed in the morning.  256 
 257 
Although the horses were fed identical meals in the morning and afternoon, there was a larger 258 
insulin response after the morning meal. This may be due to the ‘dawn phenomenon’, an 259 
early morning increase in insulin secretion initiated by an increase in glucose production. It is 260 
seen in humans and is thought to be a physiological circadian variation in hepatic insulin 261 
sensitivity induced by preceding changes in catecholamine and/or growth hormone secretion 262 
[25]. A similar response has been shown in non-obese humans. Although they consumed 263 
only 20% of total dietary energy at breakfast, subjects secreted similar quantities of insulin to 264 
those seen in response to lunch and dinner, which each contained 40% of the total dietary 265 
energy [26]. Similarly, in response to the afternoon meal, the rise and fall of insulin secretion 266 
was not as rapid as the response after the morning meal. Another common response 267 
between human and equine subjects was that the majority of the insulin secretory response 268 
was seen within the first two hours after a meal. 269 
 270 
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It has been demonstrated previously that porcine and bovine GH as well as eGH increase 271 
insulin concentrations in the horse [27,28]. Buonomo et al. [27] showed this increase was 272 
accompanied by a slight but significant increase in blood glucose, based on a single blood 273 
sample taken just prior to a GH injection of 30 mg/d, given over a period of 5 days. 274 
de Graaf-Roelfsema et al. [28] administered a dose of 5 mg eGH/horse for 2 days, followed 275 
by 10 mg eGH/horse for the remaining days, over an 11 to 15 day period. This resulted in an 276 
increase in basal insulin concentrations from measurements obtained by the use of a 277 
euglycaemic-hyperinsulinaemic clamp (HEC) technique from 62.0 ± 52.7 pmol/l in the controls 278 
to 163.0 ± 77.7 pmol/l in the horses receiving the eGH injections.  The increase in basal 279 
insulin concentrations lasted for up to 72 h after the final eGH injection.  Horses treated with 280 
eGH returned to basal insulin concentration comparable to the control horses within 48 hours 281 
of treatment ceasing. This apparent shorter time to return to pre-treatment concentrations 282 
may have been influenced by the exercise regimen the horses were undertaking. Although 283 
exercise is purported to assist with enhancing insulin sensitivity in insulin-resistant horses 284 
[19,20], there was little impact seen here of exercise reducing the hyperinsulinaemia that 285 
accompanies GH therapy. The eGH-treated horses in the present study achieved similar 286 
basal insulin concentrations to those reported in non-exercised horses [28].  287 
 288 
Furthermore, the rapid decrease of basal insulin concentrations in the GH-treated geldings 289 
may be due to gender. The present study used geldings whereas the de Graaf-Roelfsema et 290 
al. [28] study used mares. Sessions et al. [30] found that mares who had insulin resistance 291 
induced by the infusion of a heparinised lipid solution sustained this insulin resistance for a 292 
week after treatment which was unexpected. It is unknown whether the same effect is seen in 293 
geldings or if the effect stems from interaction between the mechanisms that result in insulin 294 
resistance and female reproductive hormones.   295 
 296 
Although serum insulin concentrations in the present study were determined from a single 297 
blood sample, the timing of this sample, as evidenced by the 24-hour secretion pattern, 298 
indicates the blood sample was taken when insulin concentrations were at their lowest or at a 299 
basal level. Similarly, this study also demonstrated an increase in serum insulin 300 
concentrations in horses given exogenous eGH when compared both with the control group 301 
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and with their pre-administration insulin concentrations. Samples were not analysed for 302 
glucose. 303 
 304 
Transgenic animals which over-express GH, and human patients with acromegaly, develop, 305 
among other conditions, insulin resistance and hyperinsulinaemia [31]. Similarly, in GH 306 
deficient adults given recombinant human GH therapy, there is an acute reduction in insulin 307 
sensitivity in association with an increase in glucose and insulin concentrations. Long term 308 
insulin sensitivity gradually improves in association with an increase in lean body mass and 309 
reduction in fat mass [14]. A review by Møller and Jørgensen [32], stated that, in healthy 310 
subjects, GH decreases glucose oxidation and muscle glucose uptake in the face of 311 
unchanged endogenous glucose production and plasma glucose concentrations. This implies 312 
that GH must promote nonoxidative glucose utilisation in some nonmuscle compartment of 313 
the body. Neither the tissues nor the biochemical destination for this surplus glucose flux are 314 
known. While it is known that GH causes insulin resistance within one to two hours post 315 
administration and these effects disappear after approximately 8 h, the exact mechanism is 316 
not known [31]. Indeed it was demonstrated here that the hyperinsulinaemia was short-lived 317 
once GH injections ceased, indicating that the mechanism is quite fluid.  318 
 319 
As shown in this study, eGH treatment caused an increase in serum insulin concentrations in 320 
these horses. It is unclear how long eGH administration would need to continue until insulin 321 
sensitivity improved in response to changes in body composition. Due to individual variation in 322 
the response to exogenous GH, as evidenced by the large error bars during the treatment 323 
period in Figure 3B , it cannot be determined by what degree insulin concentrations are likely 324 
to rise. This becomes very important when dealing with obese, insulin-resistant ponies as 325 
they are faced with the real possibility of developing laminitis. Several studies have clearly 326 
shown that laminitis can be triggered by hyperinsulinaemia, although whether this is due to 327 
the magnitude or the duration of the hyperinsulinaemic state has not been determined [8,9]. 328 
 329 
Growth hormone stimulates the liver to produce the mediator hormone IGF-1. Treatment of 330 
human patients suffering non-insulin dependent diabetes mellitus (NIDDM) with recombinant 331 
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human IGF-1 for 3 months or more, resulted in an improvement in glycaemic control with 332 
reduced fasting plasma glucose and insulin concentrations in conjunction with a sustained 333 
rise in serum IGF-1 above the normal physiological range. There was a reduction in fat mass, 334 
which may partly explain improved insulin sensitivity [31]. However, high doses are required 335 
to obtain the desired effects, resulting in a significant number of side-effects which has lead to 336 
IGF-1 therapy falling from favour as a treatment for NIDDM [31]. 337 
 338 
The administration of exogenous eGH in these horses resulted 2-fold to 4-fold increase in 339 
serum IGF-1 concentrations [15], which is well above the normal physiological range [24]. 340 
However, although high IGF-1 concentrations were maintained for the duration of eGH 341 
treatment, it does not appear they had any effect in compensating for insulin, thereby 342 
reducing serum insulin concentrations, as predicted. Again, it is likely that the treatment 343 
period was too short to have the desired effect, especially if the benefits are driven by the 344 
reduction of fat mass. 345 
 346 
Although the administration of eGH did lead to elevated IGF-1 concentrations in these horses, 347 
this did not have any effect on reducing serum insulin concentrations. Instead, insulin 348 
concentrations were more likely influenced directly by eGH injections, leading to an increase 349 
in serum insulin concentration, which could not be offset by daily exercise. This effect would 350 
be detrimental to equids already presenting with hyperinsulinaemia, suggesting that eGH 351 
therapy in such horses or ponies should not be recommended. While long term administration 352 
of eGH may ultimately lead to a reduction in serum insulin concentrations, due to changes in 353 
body composition, the risk of such animals contracting laminitis due to hyperinsulinaemia in 354 
the meantime may be too great. 355 
356 
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Materials 357 
aAngiocath, Becton Dickinson, Sandy, UT 358 
bTuta, Lane Cove, NSW, Australia 359 
cBD, Becton Dickinson, Sandy, UT 360 
dVacutainer, Becton Dickinson, Franklin Lakes, NJ 361 
eSiemens Count-a-Coat Insulin RIA, Siemens Medical Solutions Diagnostics, Los Angeles, 362 
CA 363 
fBresagen, Adelaide, SA, Australia 364 
gGraphpad Prism 5 for Windows, La Jolla, CA 365 
hSigmaplot, Jandell Scientific, Pala Alto, CA 366 
iMicrosoft Office, Microsoft Corporation, Redmond, WA 367 
 368 
Table 1. Incremental exercise program undertaken by 12 horses for 7 weeks. Heart rates 369 
were maintained at 150 to 160 bpm for the times indicated. The shaded section indicates the 370 
period of GH administration 371 
 372 
Work time (mins) 
Week Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 
1 10 10 10 12 12 12 
2 14 15 15 15 15 15 
3 16 17 18 19 20 20 
4 20 20 20 20 20 20 
5 22 23 24 25 25 26 
6 27 27 27 27 27 27 
7 29 30 30 30 30 30 
 373 
 374 
 375 
Figure legends  376 
 377 
Figure 1.The mean 24-hour secretion pattern (± SE) of serum cortisol (○) (A) and serum 378 
insulin (●) (B) concentrations in 12 unexercised, mature geldings. The dashed vertical lines 379 
indicate feeding times; the hatched section shows the hours of darkness. 380 
 381 
Figure 2. Daily basal serum insulin concentrations in 6 control horses undergoing an 382 
incremental conditioning program, showing no effect of exercise:  y0 = 10.2 + 0.07x, P = 0.4,    383 
r2 = 0.01. The vertical dashed lines show the eGH administration period for the treatment 384 
group. Samples with insulin concentrations below the lowest standard were omitted from the 385 
analysis. 386 
 387 
Figure 3. Mean serum insulin concentrations  of control horses (n=6) (●) and horses treated 388 
with daily injections of eGH (n=6) (○)(Plot A; transformed data with 95% confidence intervals). 389 
Plot B shows the observed mean serum insulin concentration (± SE) of the two groups. The 390 
vertical dashed lines show the eGH administration period for the treatment group.  391 
 392 
  393 
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